JP Morgan Chase’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $321M | Sell |
|
|||||
|
2021
Q1 | $346M | Sell |
|
|||||
|
2020
Q4 | $674M | Buy |
|
|||||
|
2020
Q3 | $472M | Buy |
|
|||||
|
2020
Q2 | $429M | Buy |
|
|||||
|
2020
Q1 | $265M | Sell |
|
|||||
|
2019
Q4 | $528M | Buy |
|
|||||
|
2019
Q3 | $467M | Buy |
|
|||||
|
2019
Q2 | $387M | Sell |
|
|||||
|
2019
Q1 | $641M | Buy |
|
|||||
|
2018
Q4 | $425M | Buy |
|
|||||
|
2018
Q3 | $496M | Buy |
|
|||||
|
2018
Q2 | $181M | Buy |
|
|||||
|
2018
Q1 | $91M | Sell |
|
|||||
|
2017
Q4 | $109M | Sell |
|
|||||
|
2017
Q3 | $248M | Buy |
|
|||||
|
2017
Q2 | $160M | Sell |
|
|||||
|
2017
Q1 | $372M | Buy |
|
|||||
|
2016
Q4 | $210M | Sell |
|
|||||
|
2016
Q3 | $691M | Buy |
|
|||||
|
2016
Q2 | $572M | Sell |
|
|||||
|
2016
Q1 | $711M | Buy |
|
|||||
|
2015
Q4 | $923M | Buy |
|
|||||
|
2015
Q3 | $747M | Sell |
|
|||||
|
2015
Q2 | $960M | Sell |
|
|||||
|
2015
Q1 | $960M | Sell |
|
|||||
|
2014
Q4 | $1.21B | Sell |
|
|||||
|
2014
Q3 | $1.12B | Sell |
|
|||||
|
2014
Q2 | $1.1B | Sell |
|
|||||
|
2014
Q1 | $1.12B | Buy |
|
|||||
|
2013
Q4 | $818M | Buy |
|
|||||
|
2013
Q3 | $591M | Buy |
|
|||||
|
2013
Q2 | $348M | Buy |
|